Fairfield Bio
Bronx, US · Founded 2025 · Delaware corporation
Founders & leadership
KS
Kevin SlavinNamed on SEC filing
MW
Mitchell WolfeNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$450K disclosed across 1 round · 2026
▶$450KraisedFeb 2026 · 1 investors · OtherRule 506(b)
▶$450KraisedFeb 2026 · 1 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Kevin SlavinExecutive Officer, Director
- Mitchell WolfeExecutive Officer, Director
- Offering amount
- $2M
- Amount sold
- $450K
- Proceeds to insiders
- $350K
- First sale
- Jan 2026
- Incorporated
- Corporation, Delaware, 2025
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- How much funding has Fairfield Bio raised?
- Fairfield Bio has disclosed $450K raised across 1 round.
- Where is Fairfield Bio headquartered?
- Fairfield Bio is headquartered in Bronx, US.